Have a personal or library account? Click to login
Mesenchymal Stem Cells Versus Covid-19. Can they Win the Battle? Cover

Mesenchymal Stem Cells Versus Covid-19. Can they Win the Battle?

EABR. Experimental and Applied Biomedical Research
Volume 26 (2025): Issue 2 (June 2025)
By: Amra Ramovic Hamzagic,  Dragica Miloradovic,  Dragana Miloradovic,  Zeljko Ivosevic and  Biljana Ljujic  
Open Access
|Dec 2025

Authors

Amra Ramovic Hamzagic

State University of Novi Pazar, Department of biomedical sciences, Novi Pazar, Serbia

Dragica Miloradovic

University of Kragujevac, Faculty of Medical Sciences, Department of Genetics, Kragujevac, Serbia

Dragana Miloradovic

University of Kragujevac, Faculty of Medical Sciences, Department of Genetics, Kragujevac, Serbia

Zeljko Ivosevic

University of Kragujevac, Faculty of Medical Sciences, Department of Genetics, Kragujevac, Serbia

Biljana Ljujic

bljujic74@gmail.com

University of Kragujevac, Faculty of Medical Sciences, Department of Genetics, Kragujevac, Serbia
DOI: https://doi.org/10.2478/sjecr-2021-0024 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 115 - 130
Submitted on: Mar 23, 2021
|
Accepted on: Apr 3, 2021
|
Published on: Dec 31, 2025
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Mesenchymal stem cells,
inflammation,
covid-19,
pneumonia,
ARDS
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2025 Amra Ramovic Hamzagic, Dragica Miloradovic, Dragana Miloradovic, Zeljko Ivosevic, Biljana Ljujic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 26 (2025): Issue 2 (June 2025)Next article